United Therapeutics Corp (UTHR)
$44.91
0.10 (+0.22%)
| CAPS Rating |
|
|---|---|
| Open | $44.50 |
| Previous Close | $44.81 |
| Daily Range | $44.25 - $45.08 |
| 52-Week Range | $23.82 - $50.48 |
| Market Cap | $2.42B |
| P/E Ratio | 14.09 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 627,074 |
| Average Daily Volume | 705,000 |
How do you think UTHR will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
UTHR Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
UTHR News and Commentary
- U.S. female CEOs' pay fell more than men's-survey – Reuters
- 3 Stocks Ready to Roar – The Motley Fool
- Fighting an Incurable Disease – The Motley Fool
- Will the FDA Approve These Drugs? – The Motley Fool
- You Are About to Lose a Fortune – The Motley Fool
- InterMune Batting .500 – The Motley Fool
- 5 Stocks You May Be Thankful For – The Motley Fool
- Best. Investments. Ever. – The Motley Fool
- Get Ready for the Fall – The Motley Fool
- Still Liking Gilead, Warts and All – The Motley Fool
- Start Making $53,200 Today – The Motley Fool
- Gilead Gets Synergistic – The Motley Fool
- Betting on Approval for This Orphan Drug – The Motley Fool
- Learn From the Decisive Encysive Deal – The Motley Fool
- Can Encysive Catch the Competition? – The Motley Fool
- The Way to Prosperity – The Motley Fool
- Is There Value in This Hypertension Fighter? – The Motley Fool
- The Way to Prosperity – The Motley Fool
- More Than Momentum: Stocks Rising for a Reason – The Motley Fool
- Start Making $75,000 Today – The Motley Fool


RSS Headlines
Fool UK